Subscribe to Newsletter

Subspecialties

Subspecialties Cornea / Ocular Surface

A Tired Eye Tirade

| Mark Hillen

Why is public awareness of dry eye so disturbingly low, and what can be done to change this?

Subspecialties Imaging & Diagnostics

Positive response to swept-source OCT Cataract and Refractive Imaging Platform at ESCRS

The feedback and reactions to the first public presentation of Heidelberg Engineering’s new Cataract and Refractive Imaging Platform* at the ESCRS in Barcelona were extremely positive. Many leading ophthalmologists visited Heidelberg Engineering’s booth for a hands-on preview of the swept-source OCT Cataract and Refractive Imaging Platform and had the chance to experience its versatility. Have a look at this Eyewire TV to find out more.

Subspecialties Retina

Aflibercept in Europe: Setting New Standards in Retinal Disease Care

Strength and durability in the real world

Subspecialties Retina

Light Years Ahead

| Roisin McGuigan

What if there was an imaging technique that could detect retinal disease processes before any structural damage had even occurred?

Subspecialties Basic & Translational Research

AMD Clinical Trials

| Mark Hillen, Roisin McGuigan

AMD is the leading cause of blindness in developed countries, and the third-leading cause in developing countries.

Subspecialties Retina

Interleukin Forward to a Promising Future in AMD

| Mark Hillen

A novel signaling pathway that leads to choroidal neovascularization has been identified – with obvious therapeutic potential

Subspecialties Retina

First, Do No Harm

| Mark Hillen

A new study concludes that most surgical procedures used to treat optic disc pits are of no benefit – and may even be harmfu

Subspecialties Retina

The Poor Man’s Aflibercept?

| Michael Schubert

Like bevacizumab before it, ophthalmologists are trying off-label ziv-aflibercept (formulated for systemic use) in the eye. Masterstroke or madness?

Subspecialties Retina

From Intestine to Eye

| Michael Schubert

Gut microbes may be responsible for activating the T-cells that cause autoimmune uveitis

Subspecialties Retina

New Kid on the Block

| Michael Schubert

Can amniotic stem cells suppress pathologic retinal neovascularization?

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer element

This new disclaimer element is now part of all brands. It is editable on the start page and will be shown on all pages

Once confirmed we store a cookie to not show the disclaimer again.